Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 3 | 2021 | 22 | 1.370 |
Why?
|
| Pregnancy | 14 | 2021 | 827 | 0.900 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 21 | 0.630 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2017 | 3 | 0.620 |
Why?
|
| Fetal Death | 1 | 2017 | 6 | 0.620 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 24 | 0.600 |
Why?
|
| Colon | 1 | 2017 | 56 | 0.590 |
Why?
|
| Teratoma | 1 | 2016 | 12 | 0.580 |
Why?
|
| Fetal Diseases | 1 | 2016 | 16 | 0.570 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 30 | 0.560 |
Why?
|
| Fetus | 1 | 2016 | 79 | 0.560 |
Why?
|
| Angiotensinogen | 1 | 2016 | 73 | 0.550 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 105 | 0.550 |
Why?
|
| Placenta | 1 | 2016 | 66 | 0.540 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 55 | 0.540 |
Why?
|
| Renin | 1 | 2016 | 113 | 0.540 |
Why?
|
| Urinary Bladder | 1 | 2017 | 165 | 0.530 |
Why?
|
| Endothelial Cells | 1 | 2016 | 180 | 0.520 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 182 | 0.510 |
Why?
|
| Kidney Diseases | 1 | 2016 | 239 | 0.470 |
Why?
|
| Vaginosis, Bacterial | 2 | 2009 | 6 | 0.420 |
Why?
|
| Blood Pressure | 1 | 2016 | 813 | 0.420 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2009 | 28 | 0.410 |
Why?
|
| Pregnancy Trimesters | 1 | 2010 | 3 | 0.380 |
Why?
|
| Immune System | 1 | 2010 | 8 | 0.380 |
Why?
|
| Prenatal Care | 2 | 2008 | 46 | 0.380 |
Why?
|
| Chorioamnionitis | 1 | 2009 | 8 | 0.340 |
Why?
|
| Cytokines | 1 | 2010 | 244 | 0.340 |
Why?
|
| Female | 14 | 2021 | 18414 | 0.330 |
Why?
|
| Premature Birth | 1 | 2008 | 39 | 0.320 |
Why?
|
| Fetal Monitoring | 1 | 2007 | 3 | 0.310 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 80 | 0.310 |
Why?
|
| Employment | 1 | 2007 | 49 | 0.300 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 494 | 0.260 |
Why?
|
| Gestational Age | 3 | 2016 | 96 | 0.250 |
Why?
|
| Humans | 14 | 2021 | 29614 | 0.250 |
Why?
|
| Clinical Clerkship | 2 | 2016 | 41 | 0.160 |
Why?
|
| Postnatal Care | 1 | 2018 | 5 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2018 | 119 | 0.150 |
Why?
|
| Sacrococcygeal Region | 1 | 2016 | 5 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2016 | 7 | 0.150 |
Why?
|
| Vasoconstriction | 1 | 2016 | 40 | 0.140 |
Why?
|
| Risk Factors | 2 | 2018 | 3612 | 0.140 |
Why?
|
| Vasodilation | 1 | 2016 | 87 | 0.140 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 50 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 249 | 0.140 |
Why?
|
| Prenatal Diagnosis | 2 | 2021 | 21 | 0.130 |
Why?
|
| Labor Stage, First | 1 | 2015 | 6 | 0.130 |
Why?
|
| Albuminuria | 1 | 2016 | 178 | 0.130 |
Why?
|
| Obstetrics | 1 | 2015 | 16 | 0.130 |
Why?
|
| Adult | 5 | 2017 | 8535 | 0.130 |
Why?
|
| Phenotype | 1 | 2016 | 634 | 0.120 |
Why?
|
| Students, Medical | 1 | 2016 | 121 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2015 | 86 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 713 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 840 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2016 | 674 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2010 | 62 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 984 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2010 | 732 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2010 | 14 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2010 | 10 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2010 | 18 | 0.100 |
Why?
|
| Demography | 1 | 2010 | 105 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 22 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 427 | 0.090 |
Why?
|
| Perinatal Care | 1 | 2009 | 1 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 2009 | 5 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2010 | 171 | 0.080 |
Why?
|
| Length of Stay | 1 | 2010 | 296 | 0.080 |
Why?
|
| Cerclage, Cervical | 1 | 2008 | 6 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 52 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2008 | 62 | 0.080 |
Why?
|
| Heart Rate, Fetal | 1 | 2007 | 7 | 0.080 |
Why?
|
| Time | 1 | 2007 | 21 | 0.080 |
Why?
|
| Hearing | 1 | 2007 | 11 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2007 | 47 | 0.080 |
Why?
|
| Steroids | 1 | 2007 | 36 | 0.080 |
Why?
|
| Inflammation | 1 | 2010 | 511 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2007 | 84 | 0.070 |
Why?
|
| Male | 4 | 2017 | 18037 | 0.070 |
Why?
|
| Occupational Health | 1 | 2007 | 77 | 0.070 |
Why?
|
| Educational Measurement | 2 | 2016 | 113 | 0.060 |
Why?
|
| Animals | 1 | 2016 | 7341 | 0.060 |
Why?
|
| Young Adult | 1 | 2010 | 2432 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2016 | 310 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2008 | 1329 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2007 | 2050 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 32 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2021 | 350 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2010 | 605 | 0.040 |
Why?
|
| Gynecology | 1 | 2016 | 15 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2015 | 176 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2010 | 3145 | 0.020 |
Why?
|
| Utah | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 16 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 12 | 0.020 |
Why?
|
| Morbidity | 1 | 2010 | 92 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 68 | 0.020 |
Why?
|
| Phototherapy | 1 | 2010 | 47 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2010 | 71 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 139 | 0.020 |
Why?
|
| Actinomycetales Infections | 1 | 2008 | 1 | 0.020 |
Why?
|
| Gardnerella vaginalis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mobiluncus | 1 | 2008 | 1 | 0.020 |
Why?
|
| Bacteroides Infections | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2008 | 6 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 13 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2008 | 17 | 0.020 |
Why?
|
| Hearing Tests | 1 | 2007 | 12 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 423 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 912 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 861 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2007 | 1708 | 0.010 |
Why?
|